ELIZABETH CORNELIUS: Open Payments
NPI 1619314622 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 12 payments from 7 companies in 2025. Trend: 2023 $33 · 2024 $0 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $126 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Grifols USA, LLC | 2 | $43 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Genentech USA, Inc. | 1 | $28 |
| Verona Pharma, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: AREXVY, FASENRA, Prolastin-C Liquid, TEZSPIRE, NEFFY, Xolair, NUCALA, Ohtuvayre.
Industry payments across MT — which companies pay providers there.
